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Neurotrophins: More to NGF than just survival
Alun M. Davies
NGF’s role in neuronal survival has tended to mask
other potential functions. But now the generation of
mice lacking both Bax – required for the death of NGF-
deprived neurons – and NGF or its receptor has shown
that NGF plays a key role in establishing cutaneous
innervation and regulating neuropeptide expression.
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Neurons are generated in excess in the developing
vertebrate nervous system, and those that are superfluous
to requirement are eliminated in a phase of cell death that
occurs shortly after they innervate their targets. Nerve
growth factor (NGF) is the founder member of a family of
structurally related secreted proteins, termed neu-
rotrophins, which promote and regulate the survival of
many kinds of neurons in the peripheral nervous system
during this stage of development. NGF is clearly required
for the survival of sympathetic neurons and sensory
neurons that mediate pain (nociceptive neurons) — these
neurons are eliminated in developing rodents treated with
function-blocking anti-NGF antibodies, and are lost in
mice homozygous for null mutations in the ngf gene or in
the trkA gene which encodes the NGF receptor tyrosine
kinase. NGF is synthesised in the peripheral target tissues
of these NGF-dependent neurons in proportion to their
innervation density, and administration of excess NGF
prevents naturally occurring cell death of these neurons
during development [1–3].
There is evidence that, in addition to its established role
in regulating the number of sympathetic and sensory
neurons that survive during development, NGF is able to
influence axonal growth and the expression of certain
neuron-specific genes. Some of the most convincing
evidence for these additional functions of NGF has come
from studying adult sensory neurons which no longer
require a supply of NGF to sustain their survival. In
cultures of these neurons, NGF enhances neurite growth
[4] and increases the expression of calcitonin gene-related
peptide (CGRP) and substance P, neuropeptides that are
expressed by a subset of nociceptive neurons [5]. It has
not, however, been possible to test the physiological
importance of endogenous NGF in regulating these
differentiated features of NGF-dependent neurons
during development, because blocking the function of
NGF or deleting the ngf or trkA genes results in the death
of these neurons [1–3].
To circumvent this impediment to studying the multiple
facets of NGF physiology during development, Patel et al.
[6] have generated mice that lack either Bax and NGF, or
Bax and TrkA. Bax is a pro-apoptotic member of the Bcl-2
family, which is required for programmed cell death in
many tissues [7]. Previous work has shown that naturally
occurring neuronal death is virtually eliminated in the
peripheral nervous system of bax–/– mice [8], and that
embryonic dorsal root ganglion (DRG) and sympathetic
neurons from these mice survive in culture in the absence
of NGF [9,10]. Patel et al. [6] found that the massive loss
of neurons observed in the dorsal root ganglia of trkA–/– or
ngf–/– mice by birth was prevented by the concomitant
absence of Bax. Indeed, there were more neurons remain-
ing in bax–/–/trkA–/– mice than in wild-type mice, suggest-
ing that naturally occurring neuronal death also failed to
take place in these mice. Many of the surviving dorsal root
ganglion neurons in newborn bax–/–/ngf–/– mice were found
to be TrkA-positive, indicating that Bax-deficiency
permits the in vivo survival of TrkA-expressing neurons in
the absence of NGF. The cell bodies of most neurons in
the dorsal root ganglia of newborn bax–/–/trkA–/– and
bax–/–/ngf–/– mice were, however, much smaller than those
of age-matched wild-type mice [6].
One of the most striking features of newborn bax–/–/trkA–/–
and bax–/–/ngf–/– mice was the virtual absence of nerve
fibres in the upper dermis and epidermis [6]. This
deficiency in cutaneous innervation was accompanied by a
marked reduction in the number of axons in cutaneous
nerves. In contrast, the distribution of sensory axons in the
superficial laminae of the spinal cord was grossly normal,
and the number of axons in dorsal roots showed a similar
increase to the number of neurons in the dorsal root
ganglia of these mice. Because skin is a major site of NGF
synthesis in the embryo [11], whereas little or no NGF is
made in the spinal cord, these results indicate that NGF
exerts a local effect in the skin, promoting and/or sustain-
ing the growth and arborisation of sensory axons during
the establishment of cutaneous innervation. Although the
local control of axonal growth by NGF has been demon-
strated both in vitro using compartment cultures [12] and
in vivo using transgenic mice in which ectopic NGF syn-
thesis led to localised hyperinnervation [13], the study by
Patel et al. [6] demonstrates the physiological relevance of
NGF in locally controlling axonal growth during develop-
ment, independent of its well-established role in regulat-
ing neuronal survival.
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The work of Patel et al. [6] also has potentially important
implications for the molecular mechanisms that mediate
the effects of NGF on axonal growth during development.
In addition to signalling via TrkA, NGF also binds to the
common neurotrophin receptor p75. This receptor has
recently been implicated in ligand-dependent regulation
of axonal growth, both in vitro and in vivo [14]. Work on
cell lines has also implicated TrkA in mediating the neuri-
togenic effects of NGF [15], but the demonstration that
cutaneous innervation is compromised in bax–/–/trkA–/–
mice [6] is important evidence that TrkA also plays a role
in mediating the effects of NGF on axonal growth in vivo.
To clarify this point, however, it will be necessary to
determine if p75 expression is affected in bax–/–/trkA–/–
mice, especially as pharmacological studies have shown
that NGF increases p75 expression in NGF-dependent
neurons, although p75 expression increases normally
during the early stages of sensory development in
embryos lacking NGF [16].
Just when and how the deficiency in cutaneous innerva-
tion develops in bax–/–/trkA–/– and bax–/–/ngf–/– mice
remains an important unanswered question. It is extremely
unlikely that initial axonal extension from sensory ganglia
is affected, not least because NGF synthesis does not com-
mence in the skin of wild-type mice until the earliest
sensory axons have already reached the skin [11]. It will,
however, be important to ascertain whether the lack of
axonal arborisations observed in the skin of older embryos
and newborn bax–/–/trkA–/– and bax–/–/ngf–/– mice is because
they never develop in the first place or because, once
formed, they are not maintained. A further intriguing
question that could be addressed in these mice is whether
the growth of cutaneous axons fails to keep pace with the
growth of the embryo. If so, this might suggest that target-
derived NGF is required for the sustained elongation of
cutaneous sensory axons during development.
The dorsal root ganglia of newborn bax–/–/trkA–/– mice also
lacked neurons that were immunoreactive for CGRP,
substance P and the Ret receptor tyrosine kinase, all of
which are normally expressed by subsets of nociceptive
neurons by birth [6]. Because CGRP and substance P are
not normally expressed in dorsal root ganglion neurons until
several days after an extensive arborisation of sensory nerve
fibres has developed in the skin, it is possible that the lack
of CGRP and substance P in newborn bax–/–/trkA–/– mice
could be an indirect consequence of the failure of cutaneous
innervation in these mice, rather than the lack of TrkA sig-
nalling per se. To address this issue, dorsal root ganglia from
bax–/–/trkA+/+ mice were placed in culture before significant
cutaneous innervation had been established in vivo, and
were grown for several days with and without NGF. Patel
et al. [6] found that CGRP immunoreactive neurons were
virtually absent in the cultures grown without NGF, but
were present in large numbers in the presence of NGF. 
Although previous in vivo and in vitro studies have
shown that NGF treatment increases the level of CGRP
and substance P expression in dorsal root ganglion
neurons [5,17], the new findings of Patel et al. [6] suggest
that signalling by NGF and TrkA plays a key role in
inducing the expression of CGRP in the majority of
sensory neurons during development. Thus, although the
induction and developmental increase in TrkA expression
in embryonic sensory neurons occurs independently of
NGF [16], NGF appears to be required for a later step in
the acquisition of the differentiated phenotype of a subset
of sensory neurons in vivo. 
Although Patel et al. [6] have established a powerful
paradigm for investigating the roles of neurotrophins in
controlling aspects of neuronal development independent
of their survival-promoting actions, a few cautionary
considerations should be born in mind and addressed in
future studies. First, recent work has shown that neuronal
death is not completely eliminated in Bax-deficient
embryos, at least in some cranial sensory ganglia. Although
more cranial sensory neurons survive in bax–/– mice com-
pared with wild-type mice, a significant proportion of
neurons still die in the absence of Bax [18]. This could
have important implications for the interpretation of some
studies if the neurons that die in bax–/– mice happen to be
a functionally distinct subset. 
A second consideration is that the interpretation of studies
of neuronal development in mice lacking both Bax and a
neurotrophic factor or its receptor would not be straight-
forward if Bax has direct or indirect effects on neuronal
development in addition to its well established pro-apop-
totic function. Bax and Bcl-2 form homodimers, and the
ratio of Bax to Bcl-2 affects the susceptibility of cells to
apoptosis [7]. Bcl-2 has recently been shown to accelerate
the maturation of early sensory neurons and enhance the
growth of axons from these neurons [19,20], as well as
promote the growth and regeneration of retinal ganglion
axons [21] independent of its anti-apoptotic actions. Thus,
even if Bax has no direct effect on neuronal differentiation
and axonal growth, it is possible that it could modulate the
effects of Bcl-2 on these aspects of neuronal cell biology.
For this reason, it will be important to investigate very
carefully in future studies whether absence of Bax per se
has any effect on neuronal differentiation and axonal
growth, and to complement studies of neuronal develop-
ment in Bax/neurotrophin double mutant mice with
studies of neurotrophin-deficient mice in which neuronal
death is prevented by an alternative approach, such as tar-
geted disruption of certain caspase genes.
These caveats aside, the experimental approach pioneered
by Patel et al. [6] has demonstrated the physiological rele-
vance of NGF in regulating target field innervation and
neuropeptide expression during development, independent
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of its role in regulating neuronal survival. This approach can
now be extended to other neurotrophic factors to clarify
more fully their physiological relevance during the phase of
naturally occurring neuronal death. 
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